Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Bronchodilator Agents

Known as: Bronchial Dilating Agents, Bronchial-Dilating Agents, Agents, Bronchial-Dilating 
A type of drug that causes small airways in the lungs to open up. Bronchodilators are inhaled and are used to treat breathing disorders, such as… Expand
National Institutes of Health

Related topics

Related topics

48 relations

Narrower (41)

AlbuterolAminophyllineAzelastine hydrochlorideBronkosol
Expand

Broader (1)

Autonomic Agents
Broncholytic EffectHistamine H1 AntagonistsIn Bloodagonists
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program.
RATIONALE The Severe Asthma Research Program cohort includes subjects with persistent asthma who have undergone detailed… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Review
2005
Review
2005
Interpretative strategies for lung function tests
SERIES “ATS/ERS TASK FORCE: STANDARDISATION OF LUNG FUNCTION TESTING” Edited by V. Brusasco, R. Crapo and G. Viegi Number 5… Expand
Highly Cited
2003
Highly Cited
2003
Health, United States, 2003; with chartbook on trends in the health of Americans
Number of drugs per 100 population 4 Total number of drugs . . . . . . . . . . . . . . . . . . . . . . . . . . . 400.3 604.3 321… Expand
Highly Cited
2003
Highly Cited
2003
Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial
BACKGROUND Inhaled long-acting beta2 agonists improve lung function and health status in symptomatic chronic obstructive… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Highly Cited
2000
Highly Cited
2000
Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial
Abstract Objectives: To determine the effect of long term inhaled corticosteroids on lung function, exacerbations, and health… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Highly Cited
2000
Highly Cited
2000
Long-term effects of budesonide or nedocromil in children with asthma.
BACKGROUND Antiinflammatory therapies, such as inhaled corticosteroids or nedocromil, are recommended for children with asthma… Expand
Highly Cited
1999
Highly Cited
1999
Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics.
The mechanisms associated with the development of severe, corticosteroid (CS)-dependent asthma are poorly understood, but likely… Expand
Review
1995
Review
1995
Nitric oxide
  • I. Rovira
  • Revista espanola de anestesiologia y reanimacion
  • 1995
    • Corpus ID: 1451622
Nitric oxide was identified as the relaxing factor derived from the endothelium in 1987. Nitric oxide synthesis allows the… Expand
Highly Cited
1994
Highly Cited
1994
Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1: The Lung Health Study
Objective. —To determine whether a program incorporating smoking intervention and use of an inhaled bronchodilator can slow the… Expand
Highly Cited
1993
Highly Cited
1993
The occurrence of sleep-disordered breathing among middle-aged adults.
BACKGROUND Limited data have suggested that sleep-disordered breathing, a condition of repeated episodes of apnea and hypopnea… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE